Merrimack Pharmaceuticals

1M6MYTD1Y5YMAX

Loading quotes...

Chart analytics

Forecast

Buy	6
Hold	4
Sell	1

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2024, Merrimack Pharmaceuticals has already paid €13.86 in dividends. The last payout was in May 2024.

Financials

In the last year, Merrimack Pharmaceuticals had revenue of €0 and net profit of -€1.07M

(EUR)	2023	YoY
Revenue	0	-
Gross profit	0	100.00%
Net profit	-1.07M	25.78%
EBITDA	910.94K	156.51%

Fundamentals

Metric	Value
Market capitalization	€193.31M
Number of shares	14.79M
52-week high/low	€13.71 - €9.95
Dividends	No
Beta	1.42
P/E ratio	-183.35
PEG ratio	0.06
P/B ratio	11.55
P/S ratio	0.00

Company profile

Merrimack Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen. Das Unternehmen wurde 1993 gegründet und hat seinen Hauptsitz in Cambridge, Massachusetts.